Akero Therapeutics saw the highest growth of 1.99% in patent filings and no patents were granted in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.99% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Akero Therapeutics’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Akero Therapeutics has been focused on protecting inventions in Australia(AU) with one publication in Q2 2024
The Australia(AU) Patent Office dominates the patent filings with nearly 33% of filings. The Australia(AU), Colombia(CO), and Israel(IL) patent Office are among the top ten patent offices where Akero Therapeutics is filings its patents..
Amgen could be the strongest competitor for Akero Therapeutics
Liver cirrhosis related patents lead Akero Therapeutics portfolio followed by liver diseases, and alcoholic fatty liver disease
Akero Therapeutics has highest number of patents in liver cirrhosis followed by liver diseases, alcoholic fatty liver disease, steatohepatitis, and non-alcoholic steatohepatitis (nash).
For comprehensive analysis of Akero Therapeutics's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
